Application 022037

Type
NDA
Sponsor
SHIRE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001INTUNIVGUANFACINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 1MG BASEYesNo
002INTUNIVGUANFACINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 2MG BASEYesNo
003INTUNIVGUANFACINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 3MG BASEYesNo
004INTUNIVGUANFACINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 4MG BASEYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
54092-513IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-513IntunivguanfacineTakeda Pharmaceuticals America, Inc.NDACurrent
54092-513IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-513IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-513IntunivguanfacineTakeda Pharmaceuticals America, Inc.NDACurrent
54092-515IntunivguanfacineTakeda Pharmaceuticals America, Inc.NDACurrent
54092-515IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-515IntunivguanfacineTakeda Pharmaceuticals America, Inc.NDACurrent
54092-515IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-515IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-517IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-517IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-517IntunivguanfacineTakeda Pharmaceuticals America, Inc.NDACurrent
54092-517IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-517IntunivguanfacineTakeda Pharmaceuticals America, Inc.NDACurrent
54092-519IntunivguanfacineTakeda Pharmaceuticals America, Inc.NDACurrent
54092-519IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-519IntunivguanfacineTakeda Pharmaceuticals America, Inc.NDACurrent
54092-519IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-519IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-520IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-520IntunivguanfacineTakeda Pharmaceuticals America, Inc.NDACurrent
54092-520IntunivguanfacineShire US Manufacturing Inc.NDACurrent
54092-520IntunivguanfacineShire US Manufacturing Inc.NDACurrent
64725-0513IntunivguanfacineTYA PharmaceuticalsNDACurrent
64725-0515IntunivguanfacineTYA PharmaceuticalsNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
61565SUPPL2020-01-14
61498SUPPL2020-01-14
58512SUPPL2019-05-02
58499SUPPL2019-05-01
53000SUPPL2018-03-15
52878SUPPL2018-03-08
50555SUPPL2017-12-01
50513SUPPL2017-11-28
6741SUPPL2016-07-12
16811SUPPL2016-07-08
16810SUPPL2015-03-19
6740SUPPL2015-03-19
38121SUPPL2014-11-20
29123SUPPL2014-11-20
51938SUPPL2014-10-17
38120SUPPL2013-08-27
29122SUPPL2013-08-27
6739SUPPL2013-02-25
16809SUPPL2013-02-21
38119SUPPL2011-06-10
29121SUPPL2011-06-10
38118SUPPL2011-03-04
29120SUPPL2011-03-02
42396ORIG2010-07-09
24235ORIG2010-07-09
38117ORIG2009-10-01
6738ORIG2009-09-10
68898ORIG1900-01-01
68897ORIG1900-01-01
68896ORIG1900-01-01
67203ORIG1900-01-01
67202ORIG1900-01-01
67201ORIG1900-01-01
67149ORIG1900-01-01
67147ORIG1900-01-01
67145ORIG1900-01-01
54116ORIG1900-01-01
54115ORIG1900-01-01
54114ORIG1900-01-01
54113ORIG1900-01-01
54112ORIG1900-01-01
51167SUPPL1900-01-01
51166SUPPL1900-01-01
51165SUPPL1900-01-01
51164SUPPL1900-01-01
51159SUPPL1900-01-01
51158SUPPL1900-01-01
51156SUPPL1900-01-01